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ABSTRACT  Cloned mouse mast cells resemble, by ultrastructure, immature mast cells observed 
in  vivo.  These  mast cell  clones can  be  grown  in  the  absence of  any other cells, facilitating 
direct investigations of their biochemistry and function. We find that cloned mast cells express 
plasma  membrane  receptors  (Fc~R) that  bind  mouse  IgE with  an  equilibrium  constant  (KA) 
similar to  that of  normal  mouse  peritoneal  mast cells.  In addition, cloned  mast cells do  not 
display detectable  la antigens and  cannot enhance  Ig secretion when  added  to  lymphocyte 
cultures or mediate natural killer lysis. In the presence of I  mM sodium butyrate, cloned mast 
cells stop dividing and acquire abundant electron-dense cytoplasmic granules similar to those 
of mature mast cells. Their histamine content increases concomitant with cytoplasmic granule 
maturation  and  may exceed  that of  untreated  mast cells  by 50-fold.  Unlike  peritoneal  mast 
cells, cloned mast cells incorporate 35S04  into chondroitin sulfates rather than heparin. 1-hese 
findings  demonstrate  that,  unlike  fully  differentiated  mouse  peritoneal  mast  cells,  cloned 
immature mouse mast cells contain no heparin and low levels of histamine. In addition, they 
establish  that  high-affinity  Fc, R  are  expressed  early  in  mast  cell  maturation,  well  before 
completion of cytoplasmic granule synthesis and mediator storage. 
We have previously reported methods to clone mast ceils with 
normal karyotypes from mouse hematopoietic tissue in vitro 
(30). Our cloned mast cells contain less histamine than normal 
mouse peritoneal mast cells and resemble immature mast cells 
by morphology. Others have described  similar findings with 
uncloned cells (22, 32, 38, 42, 43, 51, 53). Although some mast 
cells  synthesize  heparin  when  fully  differentiated  (23,  54), 
certain mast cell tumors are devoid of heparin and incorporate 
3BSO4 into chondroitin sulfate exclusively (18).  Histochemical 
evidence suggests that normal immature connective tissue mast 
cells (6) and the mast cells in the intestinal lamina propria of 
rodents (25, 50) also may synthesize glycosaminoglycans other 
than heparin, but this notion has not been confirmed directly. 
In this report, we show that cloned mast cells closely resem- 
ble,  by  ultrastructure,  immature  mast  cells  found  in  vivo. 
Cloned mast cells  incorporate 35804 preferentially into chon- 
droitin  sulfates,  confirming histochemical  evidence  that  im- 
mature  mast cells contain little  heparin.  In addition,  cloned 
mast cell proliferation, cytoplasmic granule synthesis, and me- 
diator  storage  can  be  modulated  in  vitro,  permitting  direct 
analysis of mast cell maturation. 
MATERIALS  AND  METHODS 
Antisera 
Lyt-1.2 and Lyt-2.2 antisera, prepared as described (45), were kindly donated 
by  F.  W.  Shen~; monoclonal  antibody  against  Thy-l.2  (mc-a-Thy-l.2)  was 
donated  by  Ed  Clark2; and  mc-a-Lyt-1  and  mc-a-Lyt-2  were  gifts  from  J. 
l Memorial Sloan-Kettering Cancer Center, New York, NY 
2 University of Washington, Seattle, WA 
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ATH-a-ATL  alloantisera (16)  or  mc-a-Ia  (10-3.6,  reference  35)  generously 
provided by John Freed and J. M. Kupinski  4. 
Mast Cells 
Procedures for the isolation, growth, and cloning of mast cells from mouse 
hematopoietic tissue have been previously described (30). Briefly, cells from the 
liver of a  13-d-old mouse fetus from one A/J female mated with a  C57BL/6 
male were incubated in Dulbecco's modified Eagle's medium (DME) with 4% 
heat-inactivated fetal calf serum (FCS),  5  x  10  -s M  2-mercaptoethanol and 2 
mM glutamine (DME-FCS) conditioned by concanavalin A (Con A)-activated 
BALB/c spleen cells (Con A-CM).  10 d  later, cells were distributed at limiting 
dilutions in wells containing irradiated (2,000  R) syngeneic bone marrow cells. 
Colonies appeared at  10-14 d  with a  cloning efficiency of ~10%. All colonies 
grown under these conditions were composed of cells that resembled mast cells 
by  light microscopy because of their prominent  metachromatic cytoplasmic 
granules. All colonies expressed the Ly 5+ Thy 1-, Ly I-2- phenotype of surface 
membrane glycoproteins.  No growth of mast cells was observed from preparations 
of irradiated bone marrow cells. Mast cell  lines were cloned by micromanipulation 
(30)  and  have  been  designated C1.MC/I-14.  The  cloned cells have  normal 
karyotypes and can be cultivated in large numbers (> 10  s) with doubling times in 
Con A-CM of 36-48 h. Clones are stable for at least 24 too, either alone or with 
an irradiated spleen cell feeder layer, although doubting times of cells maintained 
in Con A-CM may progressively increase. Using similar conditions, mast cell 
colonies also may be isolated from adult mouse spleen or bone marrow cells. 
Treatment of spleen or marrow cells with antiserum to Thy 1.2 and complement 
facilitates growth of mast cell colonies, which by electron microscopy contain 
>95% (usually >99%) mast ceils after 4-6 wk of culture. We have successfully 
maintained our cultures with medium conditioned by Con A-stimulated spleno- 
cytes (Con A-CM), cloned Ly 1+2  - inducer T lymphocytes (31), or WEHI-3 cells 
(32). All the cells described in this report were maintained in Con A-CM unless 
otherwise specified.  The  active growth  factor  in  the  supematant  of cloned 
Ly 1+2  -  inducer T  lymphocytes has been purified to apparent homogeneity. It 
has a pl of-6.0 and a Mr of 45,000 (30) (Nabel et al., manuscript in preparation). 
Effect of Sodium Butyrate on Mast Cells 
Marl et at. reported that p-815 murine mastocytoma cells, ordinarily devoid 
of cytoplasmic granules, underwent  graaulogenesis when exposed to sodium 
butyrate over 3--4 d  in vitro (26).  Butyrate-induced granulogenesis was accom- 
panied by a prolongation of mastocytoma doubling time and an increase in cell 
size, changes that suggested a differentiation effect. We evaluated whether sodium 
butyrate might exert similar effects on our mast cell clones. In these experiments, 
mast cells (1  x  105 cell/ml) were cultured in Con A-CM containing 10-20% 
medium conditioned by Ly 1+2  - inducer T lymphocytes (31 ) supplemented with 
various concentrations of sodium butyrate (Pfaltz and Bauer, Stamford, CT) for 
4 d. In some experiments, l-ml aliquots of cells were cultured in 24-well plates 
(Costar, Data Packaging, Cambridge, MA).  In other experiments, 5-  to  10-ml 
aliquots of cells were seeded into 25 cm  '~ tissue culture flasks (Falcon Labware, 
Oxnard, CA). The medium, including butyrate, was replaced after 48 h of culture. 
After 4 d, cells were recovered for electron microscopy and for determination of 
cell number and histamine content. 
Transmission  Electron  Microscopy (TEM) 
and Autoradiography 
Cells were fixed in suspension for 1 h  at room temperature in a mixture of 
paraformaldehyde and glutaraldehyde (9), were washed twice in 0.1  M sodium 
cacodylate buffer, pH 7.4, and were centrifuged through soft agar in a microfuge. 
The agar-embedded pellets were then processed for electron microscopy either 
by the osmium-potassium ferrocyanide (OPF)  or osmium-collidine uranyl en 
bloc (OCUB) techniques (9).  They were then dehydrated in a graded series of 
alcohols and infiltrated and embedded in a propylene oxide-Epon sequence. For 
autoradiography, asS-labeled cells (see below) were fixed and processed by the 
OCUB  techniques  as  above.  Thin  Epon  sections were  cut  with an  LKB  5 
-ultratome (LKB Instruments, Rockville, MD), were placed on copper grids and 
looped with llford  L-4 emulsion, exposed for up  to  4  mo  under desiccated 
conditions at 4°C, developed with Microdol X (Kodak), and stained lightly with 
lead citrate. Sections were examined in a Philips 400 electron microscope. 
Histamine Determination 
Histamine was routinely measured fluorometrically with an Autoanalyzer II 
3 Stanford University, Stanford, CA 
4 Johns Hopkins University, Baltimore, MD 
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(Technicon Instruments Corp., Tarrytown, NY) equipped to detect histamine in 
the 0.5-10 ng/ml range (46).  The histamine content of some samples was also 
determined before and after treatment with diamine oxidase by the isotopic- 
enzymatic method (44), with similar results. 
IgE Receptors 
The methods used to enumerate and characterize the binding properties of 
Fc~R  have been described in detail (17,  48).  Briefly, washed cells were resus- 
pended in MEM or RPMI-1640 medium with 0.01 M EDTA and 10% FCS, pH 
7.4, at 1-30 x  l0  s ceUs/ml. Cells in 0.4 ml received 0.05 ml of additional medium 
or medium containing 10 mg/ml noniodinated, affinity purified mouse mono- 
clonal IgE antibody from hybridoma H  1 DNP-~-26 (20). After 15 min at 37°C, 
~2sI-IgE, _.80% bindable to the rat basophilic leukemia cell line (16), at 100 #g/ 
ml was added in 0.05 ml for 90 min at 37°C with constant shaking. Duplicate 
determinations of binding of t2~I-IgE to  cells were made  by layering 0.2-ml 
aliquots of cells onto 0.2 ml of beat-inactivated FCS and centrifuging the tubes 
in a microfuge. The radioactivity in the cell pellets was measured in a gamma 
counter and the number of ~25I-IgE  molecules bound per cell calculated according 
to the formula: 
Mean cpm in cells witlfout excess noniodinated IgE 
-  Mean cpm in cells with excess 
noniodinated lgE (nonspecific binding) x  3.2 x  l0  s* 
cpm of I ng 12SI-lgE  cell number 
The forward rate constant (kl) of IgE binding to MC/9 was measured by 
incubating prewarmed cells (1.3  x  106/ml) with 3/~g/ml of ~z~I-labeled mouse 
monoclonal IgE at 37°C in Dulbeeco's modified Eagle's medium containing 10% 
FCS and 0.01 M EDTA with constant shaking. The binding reaction was stopped 
at various intervals by adding a 133-fold excess of unlabeled IgE. Cells in control 
tubes were incubated with a  133-fold excess of unlabeled IgE before addition of 
z25I-IgE. Nonspecific binding of radioactivity  to control cells was subtracted from 
experimental tubes to determine specific binding. The number of IgE receptors 
per cell was determined separately by incubating the cells with l0/Lg/ml of 125I- 
IgE for 90 rain as described above. To measure the dissociation rate (k-0 of IgE 
bound to MC/9, cells (1.3 x  10S/ml) were incubated with 3/~g/ml of t25I-labeled 
mouse monoclonal IgE at 37°C for  I h  in Ly 1+2  -  T  lymphocyte-conditioned 
Dulbecco's modified Eagle's medium as described above. Cells were then divided 
into two tubes, centrifuged, and resuspended in fresh medium. A  133-fold molar 
excess of unlabeled IgE or an equal volume of culture medium was added to 
each tube at to. The cells were incubated at 37°C with constant slow rotation and 
residual cell-bound 12bI-tgE was determined at various intervals. 
Synthesis of Sulfated Glycosaminoglycans 
Procedures reported previously for the characterization of guinea pig basophil 
giycosaminoglycans  were used with minor modifications (36). 
LABELING  OF  MAST  CELLS  WITH  laSS]SULFATE:  Briefly,  cloned  mast 
cells (CI.MC/9:5 x  l06 cells in 5 ml DME 4%-FCS containing 25% (v/v) Con A- 
CM) were labeled with 1 mCi sodium [~SS]sulfate (New England Nuclear, NEX- 
041) for 4-21 h at 37°C. After labeling, cells were washed three times in DME, 
an aliquot was taken for TEM autoradiographs (see above and reference 36), and 
the remainder was stored at  -70°C  for  biochemical analysis. In addition to 
CI.MC/9, we also labeled uncloned populations of mast cells derived from adult 
spleen (line  1) or bone marrow (line 2) maintained in DME-4% FCS supple- 
mented  with  medium  conditioned  by  WEHI-3  cells  (32)  and  an  uncloned 
population of mast cells derived from bone marrow (line 3) maintained in 10% 
ConA-CM conditioned by cloned Ly 1+2  -  T  lymphocytes. These preparations 
(>99% mast cells by TEM) were labeled for  12-18 h  as above except that the 
DME lacked unlabeled SO~ during the incubation period. In some experiments, 
mast cells were maintained with or without 1 mM sodium butyrate for 4 d before 
labeling with 3SSO4 as above. 
Normal mast cells were purified from peritoneal cells of 6-wk-old CBA/J mice 
(Jackson Laboratories. Bar Harbor, ME) over a metrizamide gradient as previ- 
ously described (48). After the metrizamide gradient, the ceils were washed twice 
in Minimal Essential Medium with Hanks' salts (Gibco, Grand Island Biological 
Co., Grand  Island, NY) with PIPES buffer (0.47  g/liter) and 4% FCS.  Cells 
(55-80% mast cells) were labeled with sodium [mS]sulfate  for 3~l h  in DME 
without unlabeled SO4 supplemented with 4% FCS. 
CHARACTERIZATION  OF  GLYCOSAMINOGLYCANS:  Glycosaminogly- 
cans are long chain polysaccharides consisting of repeating disaccharide units. In 
mast cell granules, glycosaminoglycans are linked to a protein core (23,  54) to 
form proteoglycans. The 3sS-labeled glycosaminoglycans of cultured mast cells 
were characterized by DEAE chromatography and sequential hydrolysis with 
*  1 ng IgE =  3.2 x  l09 molecules. highly purified mucopolysaccharidases of established substrate specificities. 
Thawed aliquots of frozen asS-labeled cells were heated in boiling water for 5 
rain to inactivate  endogenous degradative enzymes (34), and then exhaustively 
digested  with pronase P,  which solubilized  >90%  of incorporated  [3SS]sulfate. 
Glycosaminoglycans were chromatographed on DEAE-Sephadex A-25  (0.8  × 
6.9 cm column) previously equilibrated with 0.15 M NaCI, 0.01 M Tris, pH 7.5. 
Fractions were eluted in 0.5-ml volumes with a two-stage linear gradient of NaCI 
(0.15-2.0  M:2:0--4.0 M)  (36).  Glycosaminoglycans were  then  incubated  with 
specific  mucopolysaeeharidases  and  the  products  were  chromatographed  on 
Sephadex G-25 (0.6 x  24.5 cm column) equilibrated with 0.15 M NaCI, 0.01 M 
Tris, pH 7.5. Flow rate was 8 ml/h and fraction volume was 0.3 ml. 
Chondroitin AC and ABC lyases (Miles-Yeda, Elkhardt, Indiana) (41), and 
heparinase  (purified  from Flavobacterium  [19]), were  employed  according  to 
published methods. National Institutes of Health glycosaminoglycan reference 
standards were generously provided by J.  A. Cifonelli,  University of Chicago, 
Chicago, IL. 
Nonlabeled glycosaminoglycans and degradation products were detected  spec- 
trophotometricaUy by the carbazole method of Bitter  and Muir (3) with glucu- 
ronolactone as the standard. 
Evaluation of Mast Cells for Accessory Cell and 
Natural Killer Function 
Mast cell  clones were examined as previously described for the ability to 
enhance Ig secretion (31) or to mediate NK lysis (29). 
RESULTS 
Ultrastructure 
By TEM, clones MC/5 and MC/9 (Figs. 1 and 2 B) consisted 
entirely of mast cells exhibiting various degrees of maturity, as 
judged  both  by  nuclear  and  cytoplasmic  criteria.  Uneloned 
mast  cell  populations  (Fig.  2A,  C,  and  D)  contained  >99% 
mast cells. Mast cell nuclei were round with occasional nuclear 
membrane indentations,  dispersed nuclear chromatin, and oc- 
casional  small  nudeoli.  Rare  cells  exhibited  bilobed  nuclei. 
The  plasma  membrane  displayed  uniformly  distributed,  nar- 
row  short  processes  and  folds.  The  cells'  most  prominent 
ultrastructural  feature  was  cytoplasmic  granules  similar  to 
those described in immature mast cells in vivo (4--6, 24) and in 
uncloned populations  in  vitro (5,  13,  51).  These  appeared to 
develop  from  large  empty  vacuoles  in  the  active  Golgi  area 
(Fig.  3A).  Vacuoles  fdled  progressively  with  small  vesicles 
(Figs.  2 and 3 B) and then acquired dense matrix, some in the 
form of progranulelike (4-6,  24) structures  (Figs.  2 D, 3 A  and 
C). All cultures or clones contained at least a few very imma- 
ture-appearing cells that were devoid of dense granule matrix 
FIGURE  1  Typical  immature  mast  cells from  clone  MC/5  derived from  fetal  liver.  These mononuclear cells exhibit numerous 
immature granules that appear as large, membrane bounded, focally electron lucent structures containing small vesicles and/or 
dense progranules. Cells also contain mitochondria, cytoplasmic vesicles,  and a prominent Golgi area. The cell surfaces  are covered 
by short, narrow, uniform  processes.  Bar, 5/~m.  x 2,000. 
GALL1  et At.  Mast Cell Clones  437 FIGURE  2  Mast cells from mouse bone marrow (line 3: A  and  C) fetal liver (MC/9:  B), and spleen (line 1:  D). The mast cells from 
bone marrow and spleen were maintained in WEHI-3  conditioned  medium; MC/9 mast cells were maintained in Con A-CM. All 
cells contain a single eccentric nucleus and display short, narrow surface processes. The most immature cells (A)  had cytoplasmic 
vacuoles containing only a few vesicles. In more mature cells (B, C), the cytoplasmic vacuoles acquired the features of immature 
mast  cell  granules.  These  contained  variable  proportions  of  fine,  granular  material;  multiple  small,  round,  extremely dense, 
progranules, and numerous small vesicles. The most mature cells (D)  contained many granules rich  in progranules. Although all 
populations contained cells of various maturity,  line 3 appeared most immature and was comprised  predominantly of cells  like 
that shown in  A. Vesicles and  larger vacuoles appeared to originate in the active Golgi  areas (indicated  by arrows in  C).  Bars, 4 
#m. A, X 9,000;  B, X  5,500;  C, x  6,500;  D, X 8,500. 
and some were comprised predominantly of such cells (Fig. 
2.4).  The cytoplasm also contained mitochondria and small 
vesicles.  The cells had  no cytoplasmic glycogen particles or 
aggregates,  which are a  feature of basophilic leukocytes and 
other granulocytes but not of mast cells. 
Receptors  for Igf and Histamine Content 
Mast cell cultures (>99% mast cells by TEM) from bone 
marrow or spleen maintained with WEHI-3 conditioned me- 
dium, and cloned mast cells (MC/9) from fetal liver maintained 
in Con A-CM or in 10% Con A-CM conditioned by Ly 1+2  - 
inducer T lymphocytes, expressed approximately half as many 
plasma membrane receptors for IgE as normal peritoneal mast 
cells (Table I).  The MC/9  Fc,R bound mouse IgE with an 
equilibrium constant at 37°C similar to that of mature mouse 
peritoneal mast  cells  (Fig.  4  and Table  II).  The  histamine 
content of our mast cells was much less than that of mature 
peritoneal mast ceils. 
438  THE  JOURNAL  OF  CELL  BIOLOGY  -  VOLUME  95,  t982 FIGURE  3  Mast cells from bone marrow (line 2:  A  and  B) and spleen (line 1:  C)  maintained in WEHI-3 conditioned medium. The 
Golgi  region in  A  contains  numerous electron-lucent vesicles and vacuoles and occasional electron-dense progranules  (arrows) 
adjacent to immature granules. Vesicle-rich  immature granules are shown in  B, and granules containing abundant dense matrix, 
in  C. Bars, 1/tm.  A, x  14,000;  B, X  26,200;  C, x  22,800. 
Effect of Sodium Butyrate on Mast Cell 
Proliferation, Ultrastructure, and 
Histamine Content 
Cloned mast cells (MC/9) were grown in Ly 1+2  -  T  lym- 
phocyte-conditioned medium with or without  1 mM  sodium 
butyrate. After 4  d, mast cells cultured without butyrate had 
increased sevenfold (8 ×  l0  s to 5.4 ×  106), contained 0.03  pg 
histamine/cell, and had a viability by trypan blue exclusion of 
96%.  By  ultrastructure,  these  cells appeared very immature, 
with a few large cytoplasmic vacuoles that contained occasional 
small vesicles but no electron-dense granule matrix (Fig. 5A). 
By contrast, mast cells in l  mM sodium butyrate ceased divid- 
ing,  remained  viable  (87-96%  viable  cells  by  trypan  blue 
exclusion) and developed numerous cytoplasmic granules con- 
taining  abundant  electron-dense  matrix  material  (Fig.  5 B) 
similar  to  that  of mature  mast  cells  in  vivo.  Furthermore, 
butyrate-treated cells stored 50-fold more histamine (1.4 pg/ 
cell) than untreated controls. 
We investigated the effects of sodinm butyrate over an ~ 100- 
fold dose range (Table III). While mast cells grown with 1 mM 
butyrate  exhibited  profoundly  diminished  proliferation and 
markedly increased histamine content, mast cells grown in the 
presence of 0.3 mM butyrate were minimally affected. Sodium 
butyrate was toxic to cloned mast cells at concentrations -->2 
mM. 
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CELLULAR  LOCALIZATION  OF  INCORPORATED 
SODIUM  [35S]  SULFATE:  TEM autoradiographylocalized  sil- 
ver  grains  to  the  mast  cells'  cytoplasmic  granules  (Fig.  6). 
Although  the  majority  of cells  were  labeled,  the  number  of 
grains/cell  varied  widely.  In  general,  the mast cells  with the 
TABLE  I 
Histamine Content and IgE Receptors (Fc. R) of Mast 
Cell Lines 
Cell*  Histamine  S  FqR x  10-4/ce11§ 
pg/cell 
Normal  mouse  perito- 
neal mast cells 
CBA/J  9.4-10.4  32.1  +  7.3 
BALB/c  5.2-10.6  23.0 ±  5.9 
MC/9  mast  cell  clone  0.1-0.4  12.5 
(fetal liver) 
Mast cell  line 1  (spleen)  0.1-0.4  10.4 
Mast  cell  line  2  (bone  0.1-0.7  7.0 
marrow) 
Ly  1+2-/9  (inducer  T  0  0 
lymphocytes) 
YAC-1  (mouse lym-  ND  0 
phoma) 
* Normal mouse peritoneal mast cells were purified to :=-88% on a metrizamid 
gradient as described in  reference 48. Cultured  cells were maintained  as 
described in the text. 
:~ Range of 3 to 12 determinations performed over a period of weeks (spleen 
and  bone marrow lines maintained  in WEHI-3  conditioned  medium)  to a 
year (MC/9 clones maintained  in Con A  conditioned  medium).  Replicate 
simultaneous determinations of histamine content varied by <10%. 
§ Values for CBA/J  or BALB/c mast cells are M  +  SEM of five or six duplicate 
determinations, respectively. Values for cultured cells are means of duplicate 
determinations. 
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FIGURE  4  Forward rate constant  (kl)  of IgE  binding  to MC/9  (left). 
Dissociation  rate (k-l)  of IgE  bound to MC/9  (right). The data were 
normalized  by  taking  the  amount  of  IgE  bound  at  to  =  1.0.  Each 
point is the mean of duplicate  measurements. 
TABLE  II 
Binding Characteristics of IgE to Fc, R on Cloned Mouse Mast 
Cells  (MC/9)  and Mouse or Rat Peritoneal Mast Cells* 
Cell  kl  k-1  KA 
Cl. MC/9 
Mouse  (BALB/c)  peritoneal 
mast cells  (49) 
Rat peritoneal  mast cells  (49) 
M-is  -1  s -1  X  M  -1 
X  10 5  10 -4  X  10  ~ 
0.82  0.79  1.04 
1.94  1.11  1.75 
1.65  0.21  7.86 
* Association  (kl), dissociation  (k-l)  and  equilibrium  (KA)  constants were 
determined as described in Materials and Methods. 
FIGURE  5  Cloned  mast  cells  derived  from  fetal  liver  (MC/9)  grown  in  Con  A-CM  supplemented  with  15%  Ly  1+2  -  inducer  T 
lymphocyte-conditioned  medium.  The cell  in  A,  cultured  without  sodium  butyrate,  contains  cytoplasmic  vacuoles  with  a  few 
small  vesicles  but  no electron-dense granule  matrix.  The cell  in  B,  cultured  for 4  d  with  1  mM  sodium  butyrate,  has  numerous 
cytoplasmic  granules rich  in electron-dense granule matrix.  Bars, 2 #m.  x  8,000. 
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CHARACTERIZATION  OF  aSS-GLYCOSAMINOGLYCANS.  As- 
sessment of the relative charge of the cloned mast cell (MC/9) 
35S-glycosaminoglycans, as determined by chromatography on 
DEAE  cellulose,  revealed  a  macromolecular  peak which  ap- 
peared coincident with the chrondroitin sulfate reference stand- 
ard (Fig. 7). Chromatography on Sepharose 4B established that 
the 35S-glycosaminoglycans had an average Mr of 20,000 dal- 
tons (Fig.  8). These aSS-macromolecules,  and the chondroitin 
sulfate  standard,  were  susceptible  to  complete  hydrolysis  to 
disaccharides  by  chondroitin  ABC  or  AC  lyase,  but  were 
insensitive  to heparinase  (Fig.  8),  indicating  that  they repre- 
TABLE  III 
Sodium Butyrate Decreases Mast Cell Proliferation and 
Increases Mast Cell Histamine Content 
Sodium butyrate  Doubling  Histamine 
concentration  time  content 
mM  h  pg/cell 
0  20.4  0.07 
0.01  20.5  0.06 
0.04  20.5  0.06 
0.11  21.5  0.06 
0.33  25.8  0.08 
1.00  132.0  0.50 
Cloned  mast cells  (MC/9)  were  cultured  for 4 d  with  or without  sodium 
butyrate as described in the text. 
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FIGURE  7  DEAE-Sephadex A-25 column  (0.8 X 6.9 cm) chromatog- 
raphy of  pronase-digested cloned  mast cells  (MC/9)  labeled with 
[aSS]sulfate  for 4  or 21  h  (see text).  The  bar  indicates  the elution 
pattern  of the chondroitin sulfate reference standard. 
I0 
8 
=¢ 
6 
2 
0 
I0 
Dextron  Hep 
Bl~e  Ch~S  HS  NaCI 
,  I  l 
14  18  22  26  30  34 
FRACTION VOLUME (ml) 
FIGURE  8  Sepharose 48 column  (0.6 X  110 cm) chromatography of 
pronase-digested cloned mast cells (MC/9) labeled with [aSS]sulfate 
for  21  h  (see text). The column  was calibrated with  Dextran Blue, 
National  Institutes of Health reference standard glycosaminoglycans 
(Ch-6-S, chondroitin-6-sulfate;  HS, heparan sulfate;  Hep, heparin), 
and  NaCl. 
FIGURE  6  Electron microscopic  autoradiography  of 35S-labeled im- 
mature granules in  a closed mouse mast cell  (MC/9)  after a 2-too 
exposure of  emulsion.  Most  silver  grains  appear  over  the  large, 
vesicle-rich cytoplasmic  granules.  Bar, 2 #m.  x  6,000. 
sented  chondroitin  ABC  or  AC  lyase-sensitive  chondroitin- 
sulfates without detectable heparin or dermatan sulfate (chon- 
droitin  sulfate  B).  Similar  sulfated  glycosaminoglycans  were 
synthesized by mast cells incubated with 35SO4 for 4,  12 (data 
not shown),  and 21  h.  By single  dimensional  electrophoresis 
(49), these molecules had charge characteristics similar to those 
of the  chondroitins.  Mast  cells  from  spleen  (line  1)  or bone 
marrow (line 2 and line 3) also incorporated 3sSO4 into chon- 
droitin sulfates, not heparin. MC/9 or bone marrow line 3 mast 
cells, cultured for 4 d with 1 mM sodium butyrate, synthesized 
35S-glycosaminoglycans identical to those of mast cells grown 
without butyrate,  as judged by DEAE cellulose chromatogra- 
phy and susceptibility  to enzymatic degradation.  Although it 
did not induce synthesis of heparin, butyrate augmented mast 
cell  storage  of  chondroitin  sulfate.  For  example,  butyrate- 
treated bone marrow mast cells  (line  3) contained  81% more 
[3SS]chondroitin  sulfates  after  an  18-h  incubation  with  3SSO4 
than untreated controls. Chromatographic (DEAE) analysis of 
mast cell culture medium failed to detect secreted 35S-macro- 
molecules. 
In contrast  to cloned  mast cells,  uncloned  peritoneal  mast 
cells  incorporated  35SO4 predominantly  into  heparin.  These 
glycosaminoglycans  eluted  from  DEAE  cellulose  as  a  single 
peak between  1.0 and 2.0 M NaCI. These 35S-macromolecules, 
and  the  heparin  reference  standard,  were  susceptible  to  hy- 
drolysis to disaccharides by heparinase but were insensitive to 
chondroitin ABC or AC lyase. 
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F~GURE 9  Sephadex G-25 column  (0.6 x  24.5 cm) chromatography 
of  aliquots  of  pronase-digested  asS-labeled  cloned  mast  cells 
(MC/9)  without  additional treatment  (control)  or after treatment 
with purified heparinase or chrondroitin ABC or AC lyase (chondro- 
itinase  ABC  or AC).  Bars  indicate  the  elution  patterns  of  native 
glycosaminoglycan standards (GAG)  and their disaccharide degra- 
dation products (DS). The MC/9 macromolecules labeled with ass 
during either a 4- or 21-h incubation were degraded to disaccharides 
by chondroitin ABC or AC lyase, but were unaffected by heparinase. 
Accessory Cell Function and Natural Killer Lysis 
Mast cells from three clones derived from fetal liver were 
unable to alter Ig secretion when added to enriched B lympho- 
cytes. Data from a typical experiment are shown in Table IV. 
Analysis of mast cell clones with monoclonal antisera failed to 
detect Ia antigens. 
Three mast cell clones from fetal liver or bone marrow did 
not lyse the YAC-I, EL-4, RL-12, and MBL-2 lymphomas and 
the P815 mastocytoma. A  representative experiment is shown 
in Table V. 
DISCUSSION 
Cloned  mast  cells  resembled  by ultrastructure  proliferating 
immature mast cells found in vivo (4-6, 24).  Like immature 
mast cells,  these clones contained cytoplasmic granules with 
numerous small vesicles and various amounts of electron dense 
progranulelike structures. Despite their immature appearance 
by ultrastructure and their low histamine content, cloned mast 
cells expressed nearly as many Fc,R as mature peritoneal mast 
cells. In addition, the Fc,R of cloned mast ceils bound IgE with 
an equilibrium constant similar to that of normal mouse peri- 
toneal mast cells.  Uncloned rat mast cells also express Fc,  R 
when their histamine content is very low (14),  supporting the 
notion that incorporation of Fc,R into the plasma membrane 
represents an early event in the program of mast cell differen- 
tiation.  While  some  mast  cell-like  lines  reportedly  bear  Ia 
antigens (42, 51), mouse (7, 52) and rat (28) mature peritoneal 
mast cells do not express Ia antigens detectable by alloantisera. 
We have not detected Ia antigens on the surface membranes of 
cloned  mast  cells  by  immunofluorescence  with  monoclonal 
reagents. Although expression may vary according to culture 
conditions, degree of differentiation (47), or source of antisera, 
we have not observed Ia expression at any time with the ceils 
described in this report. 
The relationship of mast ceils to basophils has been widely 
discussed  (12).  Basophils  are bone marrow-derived granulo- 
cytes that  normally circulate  in the  blood and,  unlike  mast 
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cells, are not ordinarily found in connective tissues.  Although 
basophils and mast cells express certain biochemical and func- 
tional similarities, they are not identical. Electron microscopy 
can  be  used  to distinguish  basophils  from mast  cells  in  all 
mammalian species,  including the mouse (8,  10). Ultrastruc- 
turally,  our cloned mast cells  resemble  immature  mast cells 
found in vivo, not mouse basophils. Mouse basophils lack the 
uniform surface  processes  of normal  and  cloned mast  cells, 
have a  more central  and  polylobed nucleus,  and have  cyto- 
plasmic granules that are fewer, larger, and different in ultra- 
structure than those of mast cells (10).  Mouse tissue mast cells 
and granulocytes may share a common hematopoietic precur- 
sor (15),  although the morphology of this precursor cell,  and 
the factor(s) that control its division and differentiation, have 
not been described. We do not know whether our cloned cells 
are committed to the mast cell lineage alone; however, we have 
not  observed the development  of other cell  types using  the 
culture conditions described in this study. 
We  have  recently  reported  that  a  cloned  mouse  cell  line 
mediating natural  killer lysis (29)  resembles  immature  baso- 
phils by ultrastructure and expresses high affinity FC,R (11). 
In the present study, cloned immature mast cells were devoid 
of natural killer cell activity. We have also tested the ability of 
mast cell clones to regulate other immune functions. Mast cell 
clones do not enhance B cell Ig secretion. To date, we have not 
observed inhibition of Ig secretion by cloned mast cells  (data 
not shown).  However, histamine  (37,  39) and  perhaps  other 
mediators released by mast cells may influence T lymphocyte 
activity, and we are currently testing whether Ig secretion is 
affected by cloned mast cells  sensitized with IgE and degran- 
ulated with antigen. 
We have been able to regulate mast cell proliferation and 
induce maturation in vitro. Cloned mast cells grown in medium 
conditioned  by Ly  1+2  -  T  lymphocytes (see  Materials  and 
Methods) divided with a doubling time of ~20 h. These cells 
TABLE  IV 
Mast Cells Do Not Activate B Cells to Secrete  Ig 
No. of Ig-secreting cells after 
No. of T lym-  addition of 
phocytes or 
mast cells x  Mast ceils 
10-4/culture  T lymphocytes  (MC/9) 
0  104  -- 
1  ND  42 
2  ND  65 
5  ND  117 
10  1053  ND 
20  1313  ND 
25  ND  39 
Ly 1  + T lymphocytes or cloned mast cells were added to 5 x  108 B cells and 
incubated for 5 d. ND, not done, 
TABLE V 
Mast Cells  Do Not Mediate NK Lysis 
Specific lysis mediated by 
Effector:Target  N K-1  N K-2  MC/9 
%  %  % 
10:1  36  39  0 
5:1  38  40  0 
2.5:1  35  34  0 
Mast cells  (MC/9) or cells with  natural  killer function  (NK-1, NK-2) were 
incubated with 51Cr-labeled YAC-1 lymphoma targets for 3.5 h. appeared very immature by ultrastructure and contained only 
a  few cytoplasmic vacuoles devoid of electron-dense  granule 
matrix.  Their  histamine  content  was  very  low.  By  contrast, 
mast cells  grown  in the  same medium supplemented  with  1 
mM sodium butyrate stopped dividing, developed more mature 
cytoplasmic granules containing increased levels of 35S-glycos- 
aminoglycans, and stored up to 50 times more histamine than 
control mast cells without butyrate. These findings are consist- 
ent with earlier work identifying the cytoplasmic granule as the 
site of histamine storage in mature mast ceils (1). 
The cloned mast ceils described in this report may represent 
a  subset which  grows under selective culture conditions.  Al- 
though there is no proof that mast ceils in vivo are comprised 
of distinct subpopulations,  variations in the morphology and 
histochemistry of mast cells in different tissues have suggested 
this possibility. For example, microspectrophotometric analysis 
suggests that the sulfated glycosaminoglycans of rat intestinal 
mucosal  mast  cells,  like  those  of our  clones,  are  similar to 
chondroitin  sulfates  (50).  Mucosal  mast  ceils  also  resemble 
mast  ceil  clones  in  their  low  histamine  content  (2,  25)  and 
responsiveness to T  lymphocyte regulation (21, 33, 40). How- 
ever,  mouse mucosal  mast cells have  not  been  isolated,  and 
their glycosaminoglycans have not been analyzed by hydrolysis 
with  purified  mucopolysaccharidases.  The  number  and  IgE 
binding  affinity  of  their  Fc,  R  have  not  been  determined. 
Although the extent and causes of mast cell phenotypic varia- 
tion remain to be fully defined, some differences among mast 
cell populations may be regulated by microenvironmental fac- 
tors affecting morphology, mediator content, or maturation. In 
this  view,  the  ultrastructure  and  mediator content  of cloned 
mast cells may reflect their immaturity or the influence of their 
culture conditions, rather than their derivation from a distinct 
mast cell subpopulation.  In support of this notion, histochem- 
ical evidence has suggested that,  like mucosal mast cells, im- 
mature connective tissue mast cells in vivo contain little or no 
heparin (6). In addition, cloned mast cells resemble immature 
connective tissue mast cells by ultrastructure (4-6, 24). On the 
other hand, certain mastocytoma sublines reportedly synthesize 
heparin,  albeit  in  small  quantities,  while  they  are  rapidly 
dividing and their mediator content is very low (27).  By con- 
trast,  we have  not  detected  heparin  synthesis  in  our  cloned 
mast cells even after using butyrate to halt proliferation  and 
induce maturation. Whether other agents may induce further 
maturation and synthesis of heparin remains to be determined. 
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